CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia

Muscle and Nerve

Volumn 34, Issue 5, 2006, Pages 656-658

  Reijneveld, Jaap C ^a,b   Ginjaar, Ieke B ^c   Frankhuizen, Wendy S ^c   Notermans, Nicolette C ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CAV3 gene; Caveolin 3 deficiency; Creatine kinase; Idiopathic hyper CK emia; Myopathy

Indexed keywords

CAVEOLIN 3; CREATINE KINASE;

ADULT; AGED; ARTICLE; CAV3 GENE; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; ENZYME DEFECT; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IDIOPATHIC HYPER CREATINE KINASEMIA; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE TISSUE; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADULT; AGED; AMINO ACID SUBSTITUTION; CAVEOLIN 3; CELL NUCLEUS; CREATINE KINASE, MM FORM; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MUTATION; NEUROMUSCULAR DISEASES; UP-REGULATION;

EID: 33750491645     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20593     Document Type: Article

References (12)

1. Bär PR, Reijneveld JC, Wokke JHJ, Jacobs SCJM, Bootsma AL. Muscle damage induced by exercise: nature, prevention and repair. In: Salmons S, editor. Muscle damage. Oxford: Oxford University Press; 1997. p 1-27.
2. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373-1376.
3. de Paula F, Vainzof M, Bernardino AL, McNally E, Kunkel LM, Zatz M. Mutations in the caveolin-3 gene: when are they pathogenic? Am J Med Genet 2001;99:303-307.
4. Fischer D, Schroers A, Blumcke I, Urbach H, Zerres K, Mortier W, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003;53:233-241.
5. Ginjaar HB, van der Kooi AJ, Ceelie H, Kneppers ALJ, van Meegen M, Barth PG, et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol 2000;247:524-529.
6. McNally EM, de Sa ME, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HG, et al. Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998;7:871-877.
7. Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, et al. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002;73:65-67.
8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
9. Reijneveld JC, Notermans NC, Linssen WH, Bär PR, Wokke JH. Hyper-CK-aemia revisited. Neuromuscul Disord 2001;11:163-164.
10. Reijneveld JC, Notermans NC, Linssen WHJP, Wokke JHJ. Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 2000;23:575-579.
11. Reijneveld JC, Te Boekhorst BC, Zonderland ML, Kalmijn S, Notermans NC. Response to exercise of patients with idiopathic hyper-CK-emia. Muscle Nerve 2002;26:832-837.
12. Rowland LP, Willner J, Cerri C, DiMauro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danielli GA, Fontanari D, editors. Muscular dystrophy research: advances and new trends. Amsterdam: Excerpta Medica; 1980. p 3-13.